ArticleSensors (Basel, Switzerland)2023
Optimized Dynamic Collision Avoidance Algorithm for USV Path Planning.
Article in Sensors (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- FFRLS-MPC: An adaptive model predictive control method for robust ship course keeping.Scientific reports · 2026Article
- Advances in Optimized and Safe Path Planning of Marine Autonomous Surface Vehicles: A Review.Sensors (Basel, Switzerland) · 2026Review
- AI-Driven Hybrid Detection and Classification Framework for Secure Sleep Health IoT Networks.Clocks & sleep · 2026Review
- Explainable multi-modal deep learning for transparent cancer diagnosis: integrating radiology, clinical features, and decision visualization.Frontiers in artificial intelligence · 2026Article
- Collision Avoidance Mechanism for Swarms of Drones.Sensors (Basel, Switzerland) · 2025Article
- Trajectory tracking and obstacle avoidance in dynamic environments using an improved artificial potential field method.PloS one · 2025Article
- Driving Assistance System with Obstacle Avoidance for Electric Wheelchairs.Sensors (Basel, Switzerland) · 2024Article
- Risk-Sensitive Markov Decision Processes of USV Trajectory Planning with Time-Limited Budget.Sensors (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ship collision avoidance is a complex process that is influenced by numerous factors. In this study, we propose a novel method called the Optimal Collision Avoidance Point (OCAP) for unmanned surface vehicles (USVs) to determine when to take appropriate actions to avoid collisions. The approach combines a model that accounts for the two degrees of freedom in USV dynamics with a velocity obstacle method for obstacle detection and avoidance. The method calculates the change in the USV's navigation state based on the critical condition of collision avoidance. First, the coordinates of the optimal collision avoidance point in the current ship encounter state are calculated based on the relative velocities and kinematic parameters of the USV and obstacles. Then, the increments of the vessel's linear velocity and heading angle that can reach the optimal collision avoidance point are set as a constraint for dynamic window sampling. Finally, the algorithm evaluates the probabilities of collision hazards for trajectories that satisfy the critical condition and uses the resulting collision avoidance probability value as a criterion for course assessment. The resulting collision avoidance algorithm is optimized for USV maneuverability and is capable of handling multiple moving obstacles in real-time. Experimental results show that the OCAP algorithm has higher and more robust path-finding efficiency than the other two algorithms when the dynamic obstacle density is higher.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.